Thomas Mercher

10.7k total citations · 1 hit paper
53 papers, 4.0k citations indexed

About

Thomas Mercher is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Thomas Mercher has authored 53 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 26 papers in Hematology and 12 papers in Genetics. Recurrent topics in Thomas Mercher's work include Acute Myeloid Leukemia Research (22 papers), Epigenetics and DNA Methylation (11 papers) and RNA modifications and cancer (9 papers). Thomas Mercher is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Epigenetics and DNA Methylation (11 papers) and RNA modifications and cancer (9 papers). Thomas Mercher collaborates with scholars based in France, United States and Germany. Thomas Mercher's co-authors include D. Gary Gilliland, Ross L. Levine, Gerlinde Wernig, Benjamin H. Lee, Olivier Bernard, Sandra Moore, Rachel Okabe, Benjamin L. Ebert, Yana Pikman and Maricel Gozo and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas Mercher

52 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

2006 1.0k citations Benjamin H. Lee, Thomas Mercher et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Mercher France	27	2.4k	2.0k	1.9k	683	482	53	4.0k
Raajit K. Rampal United States	30	1.7k 0.7×	1.6k 0.8×	1.6k 0.8×	632 0.9×	376 0.8×	178	3.3k
Charles Chuah Singapore	28	1.1k 0.4×	3.5k 1.8×	2.7k 1.4×	1.6k 2.3×	222 0.5×	108	4.6k
Andrea Pellagatti United Kingdom	30	1.7k 0.7×	1.9k 1.0×	907 0.5×	130 0.2×	377 0.8×	98	3.0k
Claudia S. Huettner United States	24	1.5k 0.6×	1.5k 0.8×	689 0.4×	171 0.3×	933 1.9×	44	3.3k
Thomas Kindler Germany	27	1.5k 0.6×	1.7k 0.8×	768 0.4×	132 0.2×	342 0.7×	78	3.0k
María D. Odero Spain	32	1.8k 0.8×	1.3k 0.6×	603 0.3×	148 0.2×	250 0.5×	88	2.9k
A Strife United States	30	1.2k 0.5×	1.3k 0.7×	780 0.4×	305 0.4×	501 1.0×	59	2.7k
Keiko Okuda Japan	24	949 0.4×	1.2k 0.6×	747 0.4×	342 0.5×	717 1.5×	67	2.6k
J Groffen United States	12	762 0.3×	2.0k 1.0×	1.3k 0.7×	517 0.8×	170 0.4×	18	2.7k

Countries citing papers authored by Thomas Mercher

Since Specialization

Citations

This map shows the geographic impact of Thomas Mercher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mercher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mercher more than expected).

Fields of papers citing papers by Thomas Mercher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Mercher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mercher. The network helps show where Thomas Mercher may publish in the future.

Co-authorship network of co-authors of Thomas Mercher

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Mercher. A scholar is included among the top collaborators of Thomas Mercher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Mercher. Thomas Mercher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bagger, Frederik Otzen, Jonathan Séguin, Matheus Filgueira Bezerra, et al.. (2023). The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53. Blood. 141(18). 2245–2260. 4 indexed citations

Benbarche, Salima, Cécile K. Lopez, Eralda Salataj, et al.. (2022). Screening of ETO2-GLIS2–induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia. Science Advances. 8(6). eabg9455–eabg9455. 9 indexed citations

Mercher, Thomas, et al.. (2021). Molecular Landscapes and Models of Acute Erythroleukemia. HemaSphere. 5(5). e558–e558. 4 indexed citations

Barroca, Vilma, Cécile K. Lopez, Michel Aurrand‐Lions, et al.. (2021). JAM-C/Jam-C Expression Is Primarily Expressed in Mouse Hematopoietic Stem Cells. HemaSphere. 5(7). e594–e594.

Dossin, François, Inês Pinheiro, Jan J Żylicz, et al.. (2020). SPEN integrates transcriptional and epigenetic control of X-inactivation. Nature. 578(7795). 455–460. 140 indexed citations

Leonards, Katharina, Frederik Otzen Bagger, Cécile Thirant, et al.. (2020). Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia. Nature Communications. 11(1). 2807–2807. 18 indexed citations

Della-Valle, Véronique, Damien Roos‐Weil, Laurianne Scourzic, et al.. (2020). Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice. Blood Cancer Journal. 10(3). 38–38. 10 indexed citations

Cabon, Lauriane, Ivan Nemazanyy, Laurianne Scourzic, et al.. (2018). AIF loss deregulates hematopoiesis and reveals different adaptive metabolic responses in bone marrow cells and thymocytes. Cell Death and Differentiation. 25(5). 983–1001. 40 indexed citations

Rivera-Muñoz, Paola, Aurélie Siret, Cécile K. Lopez, et al.. (2018). Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models. Blood Advances. 2(13). 1616–1627. 10 indexed citations

10.

Lopez, Cécile K., Sébastien Malinge, Muriel Gaudry, Olivier Bernard, & Thomas Mercher. (2017). Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations. Trends in cancer. 3(9). 631–642. 14 indexed citations

11.

Tam, Winnie F., Patricia S. Hähnel, Andrea Schüler, et al.. (2012). STAT5 Is Crucial to Maintain Leukemic Stem Cells in Acute Myelogenous Leukemias Induced by MOZ-TIF2. Cancer Research. 73(1). 373–384. 26 indexed citations

12.

Liu, Jianing, Thomas Mercher, Claudia Scholl, et al.. (2012). A functional role for the histone demethylase UTX in normal and malignant hematopoietic cells. Experimental Hematology. 40(6). 487–498.e3. 23 indexed citations

13.

Koo, Sun Hoe, Brian J.P. Huntly, Yuan Wang, et al.. (2010). Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesis. Haematologica. 95(10). 1642–1650. 13 indexed citations

14.

Mullally, Ann, Steven Lane, Brian Ball, et al.. (2010). Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells. Cancer Cell. 17(6). 584–596. 285 indexed citations

15.

Cornejo, Melanie, Stephen M. Sykes, Cristina Lo Celso, et al.. (2009). A Regulatory Network Between Notch and AKT Signaling Pathways Differentially Controls Megakaryocyte Development From Hematopoietic Stem or Committed Progenitor Cells.. Blood. 114(22). 384–384. 1 indexed citations

16.

Cornejo, Melanie, Titus J. Boggon, & Thomas Mercher. (2009). JAK3: A two-faced player in hematological disorders. The International Journal of Biochemistry & Cell Biology. 41(12). 2376–2379. 73 indexed citations

17.

Bernard, Olivier, D. Gary Gilliland, & Thomas Mercher. (2009). Activation de la voie Notch par OTT-MAL dans les leucémies aiguës mégacaryoblastiques. médecine/sciences. 25(8-9). 676–678. 2 indexed citations

18.

Mercher, Thomas, Gerlinde Wernig, Ross L. Levine, et al.. (2006). JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model. Blood. 108(8). 2770–2779. 87 indexed citations

19.

Hiriart, Edwige, Henri Gruffat, Monique Buisson, et al.. (2005). Interaction of the Epstein-Barr Virus mRNA Export Factor EB2 with Human Spen Proteins SHARP, OTT1, and a Novel Member of the Family, OTT3, Links Spen Proteins with Splicing Regulation and mRNA Export. Journal of Biological Chemistry. 280(44). 36935–36945. 74 indexed citations

20.

Bernard, Olivier, Paola Ballerini, M Mauchauffé, et al.. (2001). A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia. 15(10). 1495–1504. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact